Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 16:12:699951.
doi: 10.3389/fendo.2021.699951. eCollection 2021.

Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review

Affiliations
Review

Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review

Melissa L Kozakiewicz et al. Front Endocrinol (Lausanne). .

Abstract

The endocannabinoid system (ECS) is a cell-signaling system present in multiple organ systems and is an integral part of sustaining the microenvironment necessary for early pregnancy success and maintenance. It plays a significant role in embryo development, transport and implantation as well as placentation. The current theory behind the initiation of term labor is that it is a complex, multifactorial process involving sex steroid hormones, prostaglandin production and interplay at the maternal-fetal interface resulting in increased expression of receptors and gap junctions that promote uterine activation. There is increasing evidence that, in addition to early pregnancy events, the ECS plays a regulatory role in pregnancy maintenance and the timing of labor. This review presents an overview of the ECS in pregnancy that focuses on late gestation and parturition.

Keywords: anandamide; cannabinoid receptor; endocannabinoid system; labor; myometrium; parturition; pregnancy; preterm labor.

PubMed Disclaimer

Conflict of interest statement

The author CG is the Chief Medical Officer of Nixxi (https://nixxihealth.com), a company developing preterm birth prediction tools. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Maternal plasma anandamide levels as described by Habayeb and colleagues (14) relative to levels of progesterone and estrogens during pregnancy. (Figure including levels of progesterone and estrogens published in Boron WF, Boulpaep EL: Medical Physiology, 3rd ed. Philadelphia, Elsevier, 2017. Data from Wilson JD, Foster DW, Kroenber M, Larsen PR: Williams Textbook of Endocrinology, 9th ed. Philadelphia, WB Saunders, 1998. Used with permission.)

Similar articles

Cited by

References

    1. Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, et al. . Endocannabinoid Signaling at the Periphery: 50 Years After THC. Trends Pharmacol Sci (2015) 36(5):277–96. 10.1016/j.tips.2015.02.008 - DOI - PMC - PubMed
    1. Howlett AC, Blume LC, Dalton GD. CB(1) Cannabinoid Receptors and Their Associated Proteins. Curr Med Chem (2010) 17(14):1382–93. 10.2174/092986710790980023 - DOI - PMC - PubMed
    1. Howlett AC. The Cannabinoid Receptors. Prostaglandins Other Lipid Mediat (2002) 68-69:619–31. 10.1016/S0090-6980(02)00060-6 - DOI - PubMed
    1. Booth WT, Walker NB, Lowther WT, Howlett AC. Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure. Molecules (2019) 24(20):3672. 10.3390/molecules24203672 - DOI - PMC - PubMed
    1. Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, et al. . Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage. Placenta (2009) 30(6):516–22. 10.1016/j.placenta.2009.03.015 - DOI - PubMed

Publication types

Substances